These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 24294945)

  • 21. Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients.
    Pan X; Wang P; Luo J; Wang Z; Song Y; Ye J; Hou X
    Endocrine; 2015 Apr; 48(3):834-47. PubMed ID: 25138963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ischemia-Reperfusion Injury in Fatty Liver Is Mediated by Activated NADPH Oxidase 2 in Rats.
    Kimura K; Shirabe K; Yoshizumi T; Takeishi K; Itoh S; Harimoto N; Ikegami T; Uchiyama H; Okano S; Maehara Y
    Transplantation; 2016 Apr; 100(4):791-800. PubMed ID: 26950726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor-alpha accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease.
    Zhang W; Kudo H; Kawai K; Fujisaka S; Usui I; Sugiyama T; Tsukada K; Chen N; Takahara T
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1731-6. PubMed ID: 20043871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin as additive of HTK preservation solution in cold ischemia/reperfusion injury of steatotic livers.
    Eipel C; Hübschmann U; Abshagen K; Wagner KF; Menger MD; Vollmar B
    J Surg Res; 2012 Mar; 173(1):171-9. PubMed ID: 21074785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silybin counteracts lipid excess and oxidative stress in cultured steatotic hepatic cells.
    Vecchione G; Grasselli E; Voci A; Baldini F; Grattagliano I; Wang DQ; Portincasa P; Vergani L
    World J Gastroenterol; 2016 Jul; 22(26):6016-26. PubMed ID: 27468193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling.
    Zeng X; Yang J; Hu O; Huang J; Ran L; Chen M; Zhang Y; Zhou X; Zhu J; Zhang Q; Yi L; Mi M
    Antioxid Redox Signal; 2019 Jan; 30(2):163-183. PubMed ID: 29310441
    [No Abstract]   [Full Text] [Related]  

  • 27. Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice.
    Kato H; Duarte S; Miller MG; Busuttil RW; Coito AJ
    Liver Transpl; 2019 Feb; 25(2):288-301. PubMed ID: 30358115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated multi-omic analysis identifies fatty acid binding protein 4 as a biomarker and therapeutic target of ischemia-reperfusion injury in steatotic liver transplantation.
    Yang M; Shu W; Zhai X; Yang X; Zhou H; Pan B; Li C; Lu D; Cai J; Zheng S; Jin B; Wei X; Xu X
    Cell Mol Life Sci; 2024 Feb; 81(1):83. PubMed ID: 38341383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ischemia reperfusion injury induces pyroptosis and mediates injury in steatotic liver thorough Caspase 1 activation.
    Kolachala VL; Lopez C; Shen M; Shayakhmetov D; Gupta NA
    Apoptosis; 2021 Jun; 26(5-6):361-370. PubMed ID: 33990906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decoding cell death signals in liver inflammation.
    Brenner C; Galluzzi L; Kepp O; Kroemer G
    J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidative stress impairs HIF1α activation: a novel mechanism for increased vulnerability of steatotic hepatocytes to hypoxic stress.
    Anavi S; Harmelin NB; Madar Z; Tirosh O
    Free Radic Biol Med; 2012 May; 52(9):1531-42. PubMed ID: 22343340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermittent ischaemia maintains function after ischaemia reperfusion in steatotic livers.
    Steenks M; van Baal MC; Nieuwenhuijs VB; de Bruijn MT; Schiesser M; Teo MH; Callahan T; Padbury RT; Barritt GJ
    HPB (Oxford); 2010 May; 12(4):250-61. PubMed ID: 20590895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TLR4 knockout upregulates the expression of Mfn2 and PGC-1α in a high-fat diet and ischemia-reperfusion mice model of liver injury.
    Zhang C; Jia Y; Liu B; Wang G; Zhang Y
    Life Sci; 2020 Aug; 254():117762. PubMed ID: 32437795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steatotic rat hepatocytes in primary culture are more susceptible to the acute toxic effect of acetaminophen.
    Kučera O; Al-Dury S; Lotková H; Roušar T; Rychtrmoc D; Červinková Z
    Physiol Res; 2012; 61(Suppl 2):S93-101. PubMed ID: 23130907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury.
    Llacuna L; Fernández A; Montfort CV; Matías N; Martínez L; Caballero F; Rimola A; Elena M; Morales A; Fernández-Checa JC; García-Ruiz C
    J Hepatol; 2011 May; 54(5):1002-10. PubMed ID: 21145825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ischemia–reperfusion injury in patients with fatty liver and the clinical impact of steatotic liver on hepatic surgery.
    Tashiro H; Kuroda S; Mikuriya Y; Ohdan H
    Surg Today; 2014 Sep; 44(9):1611-25. PubMed ID: 24078000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease.
    Chavez-Tapia NC; Rosso N; Tiribelli C
    BMC Gastroenterol; 2012 Mar; 12():20. PubMed ID: 22380754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A theoretical study of lipid accumulation in the liver-implications for nonalcoholic fatty liver disease.
    Schleicher J; Guthke R; Dahmen U; Dirsch O; Holzhuetter HG; Schuster S
    Biochim Biophys Acta; 2014 Jan; 1841(1):62-9. PubMed ID: 23999488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ischemia-reperfusion injury in rat fatty liver: role of nutritional status.
    Caraceni P; Nardo B; Domenicali M; Turi P; Vici M; Simoncini M; De Maria N; Trevisani F; Van Thiel DH; Derenzini M; Cavallari A; Bernardi M
    Hepatology; 1999 Apr; 29(4):1139-46. PubMed ID: 10094958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indirubin and NAD
    Teodoro JS; Varela AT; Duarte FV; Gomes AP; Palmeira CM; Rolo AP
    Eur J Clin Invest; 2018 Jun; 48(6):e12932. PubMed ID: 29603199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.